HOXA4 induces expansion of hematopoietic stem cells in vitro and confers enhancement of pro-B-cells in vivo

Stem Cells and Development

Volumn 21, Issue 1, 2012, Pages 133-142

  Fournier, Marilaine ^a   Lebert Ghali, Charles Itienne ^a   Krosl, Gorazd ^a   Bijl, Janet J ^a,b  

^a MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GREEN FLUORESCENT PROTEIN; INTERLEUKIN 7; NUCLEIC ACID BINDING PROTEIN; TRANSCRIPTION FACTOR HOXA4; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; B LYMPHOCYTE; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HEMATOPOIETIC STEM CELL; IN VITRO STUDY; IN VIVO STUDY; LYMPHOID CELL; MOUSE; MYELOID PROGENITOR CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROGENY; PROTEIN FUNCTION; STEM CELL EXPANSION;

ANIMALS; ANTIGENS, DIFFERENTIATION; ANTIGENS, SURFACE; BONE MARROW TRANSPLANTATION; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; GREEN FLUORESCENT PROTEINS; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; HOMEODOMAIN PROTEINS; HUMANS; MICE; MICE, INBRED C57BL; MYELOID CELLS; PRECURSOR CELLS, B-LYMPHOID; RECOMBINANT FUSION PROTEINS;

MUS;

EID: 84855462841     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2011.0259     Document Type: Article

References (45)

1. McGonigle GJ, TR Lappin and A Thompson2008). Grappling with the HOX network in hematopoiesis and leukemia. Front Biosci 13:4297-4308. (Pubitemid 351599685)
2. Argiropoulos B and RK Humphries2007). Hox genes in hematopoiesis and leukemogenesis. Oncogene 2647:6766-6776. (Pubitemid 47585101)
3. Sauvageau G, PM Lansdorp, CJ Eaves, DE Hogge, WH Dragowska, DS Reid, C Largman, HJ Lawrence and RK Humphries1994). Differential expression of homeobox genes in functionally distinct CD34 + subpopulations of human bone marrow cells. Proc Natl Acad Sci USA 9125:12223-12227. (Pubitemid 24368637)
4. Pineault N, CD Helgason, HJ Lawrence and RK Humphries2002). Differential expression of Hox, Meis1, and Pbx1 genes in primitive cells throughout murine hematopoietic ontogeny. Exp Hematol 301:49-57. (Pubitemid 34059217)
5. Sauvageau G, U Thorsteinsdottir, CJ Eaves, HJ Lawrence, C Largman, PM Lansdorp and RK Humphries1995). Overexpression of HOXB4 in hematopoietic cel causes the selective expansion of more primitive populations in vitro and in vivo. Genes Dev 914:1753-1765.
6. Sauvageau G, U Thorsteinsdottir, MR Hough, P Hugo, HJ Lawrence, C Largman and RK Humphries1997). Overexpression of HOXB3 in hematopoietic cells causes defective lymphoid development and progressive myeloproliferation. Immunity 61:13-22. (Pubitemid 27130211)
7. Thorsteinsdottir U, A Mamo, E Kroon, L Jerome, J Bijl, HJ Lawrence, K Humphries and G Sauvageau2002). Overexpression of the myeloid leukemia-associated Hoxa9 gene in bone marrow cells induces stem cell expansion. Blood 991:121-129.
8. Thorsteinsdottir U, G Sauvageau, MR Hough, W Dragowska, PM Lansdorp, HJ Lawrence, C Largman and RK Humphries1997). Overexpression of HOXA10 in murine hematopoietic cells perturbs both myeloid and lymphoid differentiation and leads to acute myeloid leukemia. Mol Cell Biol 171:495-505. (Pubitemid 26425639)
9. Magnusson M, AC Brun, N Miyake, J Larsson, M Ehinger, JM Bjornsson, A Wutz, M Sigvardsson and S Karlsson2007). HOXA10 is a critical regulator for hematopoietic stem cells and erythroid/megakaryocyte development. Blood 1099:3687-3696. (Pubitemid 46641717)
10. Fischbach NA, S Rozenfeld, W Shen, S Fong, D Chrobak, D Ginzinger, SC Kogan, A Radhakrishnan, MM Le Beau, C Largman and HJ Lawrence2005). HOXB6 overexpression in murine bone marrow immortalizes a myelomonocytic precursor in vitro and causes hematopoietic stem cell expansion and acute myeloid leukemia in vivo. Blood 1054:1456-1466. (Pubitemid 40223661)
11. Antonchuk J, G Sauvageau and RK Humphries2002). HOXB4-induced expansion of adult hematopoietic stem cells ex vivo. Cell 1091:39-45. (Pubitemid 34327515)
12. Buske C, M Feuring-Buske, C Abramovich, K Spiekermann, CJ Eaves, L Coulombel, G Sauvageau, DE Hogge and RK Humphries2002). Deregulated expression of HOXB4 enhances the primitive growth activity of human hematopoietic cells. Blood 1003:862-868. (Pubitemid 34832611)
13. Krosl J, P Austin, N Beslu, E Kroon, RK Humphries and G Sauvageau2003). In vitro expansion of hematopoietic stem cells by recombinant TAT-HOXB4 protein. Nat Med 911:1428-1432. (Pubitemid 37466195)
14. Krosl J, N Beslu, N Mayotte, RK Humphries and G Sauvageau2003). The competitive nature of HOXB4-transduced HSC is limited by PBX1: the generation of ultra-competitive stem cells retaining full differentiation potential. Immunity 184:561-571. (Pubitemid 36513637)
15. Bijl J, A Thompson, R Ramirez-Solis, J Krosl, DG Grier, HJ Lawrence and G Sauvageau2006). Analysis of HSC activity and compensatory Hox gene expression profile in Hoxb cluster mutant fetal liver cells. Blood 1081:116-122. (Pubitemid 43990619)
16. Brun AC, JM Bjornsson, M Magnusson, N Larsson, P Leveen, M Ehinger, E Nilsson and S Karlsson2004). Hoxb4- deficient mice undergo normal hematopoetic development but exhibit a mild proliferation defect in hematopoietic stem cells. Blood 10311:4126-4133. (Pubitemid 38685353)
17. Horan GS, R Ramirez-Solis, MS Featherstone, DJ Wolgemuth, A Bradley and RR Behringer1995). Compound mutants for the paralogous hoxa-4, hoxb-4, and hoxd-4 genes show more complete hoeotic transformations and a dose-dependent increase in the number of vertebrae transformed. Genes Dev 913:1667-1677.
18. Condie BG and MR Capecchi1994). Mice with targeted disruptions in the paralogous genes hoxa-3 and hoxd-3 reveal synergistic interactions. Nature 3706487:304-307. (Pubitemid 24250127)
19. Ivanova NB, JT Dimos, C Schaniel, JA Hackney, KA Moore and IR Lemischka2002). A stem cell molecular signature. Science 2985593:601-604.
20. Akashi K, X He, J Chen, H Iwasaki, C Niu, B Steenhard, J Zhang, J Haug and L Li2003). Transcriptional accessibility for genes of multiple tissues and hematopoietic lineages is hierarchically controlled during early hematopoiesis. Blood 1012:383-389.
21. Mikkola HK and SH Orkin2006). The journey of developing hematopoietic stem cells. Development 13319:3733-3744. (Pubitemid 44650952)
22. Lebert-Ghali CE, M Fournier, GJ Dickson, A Thompson, G Sauvageau and JJ Bijl2010). HoxA cluster is haploinsufficient for activity of hematopoietic stem and progenitor cells. Exp Hematol 3811:1074-1086.
23. Greer JM, J Puetz, KR Thomas and MR Capecchi2000). Maintenance of functional equivalence during paralogous Hox gene evolution. Nature 4036770:661-665. (Pubitemid 30104007)
24. Holland PW and J Garcia-Fernandez1996). Hox genes and chordate evolution. Dev Biol 1732:382-395. (Pubitemid 26064864)
25. Iacovino M, C Hernandez, Z Xu, G Bajwa, M Prather and M Kyba2009). A conserved role for Hox paralog group 4 in regulation of hematopoietic progenitors. Stem Cells Dev 185:783-792.
26. Strathdee G, A Sim, A Parker, D Oscier and R Brown2006). Promoter hypermethylation silences expression of the HoxA4 gene and correlates with IgVh mutational status in CLL. Leukemia 207:1326-1329. (Pubitemid 43905849)
27. Zangenberg M, L Grubach, A Aggerholm, T Silkjaer, C Juhl- Christensen, CG Nyvold, E Kjeldsen, HB Ommen and P Hokland2009). The combined expression of HOXA4 and MEIS1 is an independent prognostic factor in patients with AML. Eur J Haematol 835:439-448.
28. Markowitz D, C Hesdorffer, M Ward, S Goff and A Bank1990). Retroviral gene transfer using safe and efficient packaging cell lines. Ann NY Acad Sci 612:407-414.
29. Humphries RK, AC Eaves and CJ Eaves1981). Self-renewal of hemopoietic stem cells during mixed colony formation in vitro. Proc Natl Acad Sci USA 786:3629-3633. (Pubitemid 11062406)
30. Szilvassy SJ, RK Humphries, PM Lansdorp, AC Eaves and CJ Eaves1990). Quantitative assay for totipotent reconstituting hematopoietic stem cells by a competitive repopulation strategy. Proc Natl Acad Sci USA 8722:8736-8740. (Pubitemid 120007583)
31. Hu Y and GK Smyth2009). ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays. J Immunol Methods 347:70-78.
32. Thompson A, MF Quinn, D Grimwade, CM O Neill, MR Ahmed, S Grimes, MF McMullin, F Cotter and TR Lappin2003). Global down-regulation of HOX gene expression in PML-RARalpha + acute promyelocytic leukemia identified by small-array real-time PCR. Blood 1014:1558-1565. (Pubitemid 36182534)
33. Sharpe J, S Nonchev, A Gould, J Whiting and R Krumlauf1998). Selectivity, sharing and competitive interactions in the regulation of Hoxb genes. EMBO J 176:1788-1798. (Pubitemid 28119132)
34. Gould A, A Morrison, G Sproat, RA White and R Krumlauf1997). Positive cross-regulation and enhancer sharing: two mechanisms for specifying overlapping Hox expression patterns. Genes Dev 117:900-913. (Pubitemid 27175296)
35. Packer AI, DA Crotty, VA Elwell and DJ Wolgemuth1998). Expression of the murine Hoxa4 gene requires both autoregulation and a conserved retinoic acid response element. Development 12511:1991-1998. (Pubitemid 28297786)
36. Schmittwolf C, M Porsch, A Greiner, A Avots and AM Muller2005). HOXB4 confers a constant rate of in vitro proliferation to transduced bone marrow cells. Oncogene 244:561-572. (Pubitemid 40188561)
37. Zhang XB, BC Beard, GD Trobridge, BL Wood, GE Sale, R Sud, RK Humphries and HP Kiem2008). High incidence of leukemia in large animals after stem cell gene therapy with a HOXB4-expressing retroviral vector. J Clin Invest 1184:1502-1510. (Pubitemid 351500443)
38. Pineault N, C Abramovich, H Ohta and RK Humphries2004). Differential and common leukemogenic potentials of multiple NUP98-Hox fusion proteins alone or with Meis1. Mol Cell Biol 245:1907-1917. (Pubitemid 38248932)
39. Bijl J, J Krosl, CE Lebert-Ghali, J Vacher, N Mayotte and G Sauvageau2008). Evidence for Hox and E2A-PBX1 collaboration in mouse T-cell leukemia. Oncogene 27:6356-6364.
40. Haddad R, F Pflumio, I Vigon, G Visentin, C Auvray, S Fichelson and S Amsellem2008). The HOXB4 homeoprotein differentially promotes ex vivo expansion of early human lymphoid progenitors. Stem Cells 262:312-322. (Pubitemid 351413590)
41. Lawrence HJ, CD Helgason, G Sauvageau, S Fong, DJ Izon, RK Humphries and C Largman1997). Mice bearing a targeted interruption of the homeobox gene HOXA9 have defects in myeloid, erythroid, and lymphoid hematopoiesis. Blood 896:1922-1930. (Pubitemid 27132106)
42. Gwin K, E Frank, A Bossou and KL Medina2010). Hoxa9 regulates Flt3 in lymphohematopoietic progenitors. J Immunol 18511:6572-6583.
43. Buser A, M Stern, C Arber, M Medinger, J Halter, A Rovo, G Favre, A Lohri, A Tichelli and A Gratwohl2008). Impaired B-cell reconstitution in lymphoma patients undergoing allogeneic HSCT: an effect of p etreatment with rituximab? Bone Marrow Transplant 427:483-487.
44. Arber C, A Buser, D Heim, M Weisser, A Tyndall, A Tichelli, J Passweg and A Gratwohl2007). Septic polyarthritis with Ureaplasma urealyticum in a patient with prolonged agammaglobulinemia and B-cell aplasia after allogeneic HSCT and rituximab pretreatment. Bone Marrow Transplant 406:597-598. (Pubitemid 47382132)
45. Amsellem S, F Pflumio, D Bardinet, B Izac, P Charneau, PH Romeo, A Dubart-Kupperschmitt and S Fichelson2003). Ex vivo expansion of human hematopoietic stem cells by direct delivery of the HOXB4 homeoprotein. Nat Med 911:1423-1427. (Pubitemid 37466194)